Lexeo Therapeutics (LXEO) Cash from Investing Activities (2022 - 2026)
Lexeo Therapeutics (LXEO) posted Cash from Investing Activities of $14.26 million for Q2 2026, compared with -$39.17 million a year earlier and down 48.1% from the prior quarter.
Powered by 
Analysis
Lexeo Therapeutics (LXEO) Cash from Investing Activities (2022 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cash from Investing Activities at Lexeo Therapeutics was -$24.95 million; for FY2025, it was -$90.25 million.
- In prior years, Lexeo Therapeutics' Cash from Investing Activities was -$94.08 million in FY2024, -$165,000 in FY2023 and -$901,000 in FY2022.
- Quarterly Cash from Investing Activities has run from a low of -$101.69 million in Q4 2025 to a high of $35.01 million in Q3 2025 over five years.
- According to Business Quant data, Cash from Investing Activities for the three prior quarters was $27.46 million (Q1 2026), -$101.69 million (Q4 2025) and $35.01 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.11 Bn |
| 10 | Lexeo Therapeutics | 277.54 Mn | 277.54 Mn | - | 14.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.26 Mn |
| Mar 31, 2026 | 27.46 Mn |
| Dec 31, 2025 | -101.69 Mn |
| Sep 30, 2025 | 35.01 Mn |
| Jun 30, 2025 | -39.17 Mn |
| Mar 31, 2025 | 15.60 Mn |
| Dec 31, 2024 | -93.58 Mn |
| Sep 30, 2024 | -83,000.00 |
| Jun 30, 2024 | -218,000.00 |
| Mar 31, 2024 | -193,000.00 |
| Dec 31, 2023 | -73,000.00 |
| Sep 30, 2023 | -53,000.00 |
| Dec 31, 2022 | -107,000.00 |
API Access
Lexeo Therapeutics Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=LXEO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "LXEO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=LXEO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();